NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYubeGitHubSlack

Study

arrow_backDatasets

COVID-19 Outpatient Thrombosis Prevention Trial (ACTIV-4B)

phs002710.v1.p1dbGapdbGap FHIR

Description

An adaptive randomized double-blind placebo-controlled platform trial to compare the effectiveness of anticoagulation with antiplatelet agents and with placebo to prevent thrombotic events in patients diagnosed with COVID-19 who are not admitted to hospital as COVID-19 related symptoms are currently stable.

Summary

PlatformsBDC
Consent CodesGRU
Focus / DiseasesCOVID-19
Study DesignInterventional
Data Types--
Subjects657

Applying For Access

dbGaP FAQdbGaP Access Request Video Tutorial